COVID-19 Coagulopathy: Whom to Anticoagulate and How? What Agents to…

Rush University Medical Center

S. Jain

VTE Prophylaxis After THA: Chinese Experience

Arthroplasty Society in Asia

H. Cai

VTE Prophylaxis After THA for Asian Population: Pharmacological Prop…

Arthroplasty Society in Asia

M. Mihara

VTE Prophylaxis After THA in the Asians: Messages from 2019 AP VTE C…

Arthroplasty Society in Asia

A. Tanavalee

Cancer-Associated Thrombosis: Defining, Risk Assessment, and Prognos…

BMFcases

T. Bat, M. Carrier

How do I Recognize and Treat the VEXAS Syndrome?

Cleveland Clinic Rheumatology

P. Grayson

Acute DVT: When to and When Not to Intervene?

Venous Edge

S. Elias, C. Pena, C. Huff, R. Winokur, K. BROWN

Prevention and Treatment of Cancer-Associated Thrombosis: What Are t…

James Douketis

COVID-19: What Types of Thrombosis Are Commonly Seen? Are Anticoagul…

Mount Sinai

J. Olin

Management of Acute Pulmonary Embolism: How Long Do You Treat?

NYU Langone

N. Amoroso

Thrombus Extending into the IVC

Venous Symposium

P. Muck

COVID-19 and Thrombotic or Thromboembolic Disease: Implications for …

Keck School of Medicine of USC

L. Clavijo

Catheter Wars: The Thrombus Strikes Back

AVA 2022 Annual Scientific Meeting

A. Bulmer, P. Carr

Polycythemia Vera: Disease Overview, Treatment Landscape, and Curren…

Jerry Spivak

Duration of Anticoagulation: Provoked vs Unprovoked VTE

PERT Consortium 2022

G. Barnes

Perioperative Management of Antithrombotic Therapy

CHEST 2022 Coverage

J. Douketis

Upper Extremity Point of Care Ultrasound (POCUS)

UC San Diego Health - Hemophilia and Thrombosis Treatment Center

T. Sekayan

VTE Case-Based Discussion

ARCH Advanced Revascularization Symposium

G. Chrysant